[PDF][PDF] Inflammation in obesity, diabetes, and related disorders

TV Rohm, DT Meier, JM Olefsky, MY Donath - Immunity, 2022 - cell.com
Obesity leads to chronic, systemic inflammation and can lead to insulin resistance (IR), β-cell
dysfunction, and ultimately type 2 diabetes (T2D). This chronic inflammatory state …

[HTML][HTML] Signaling pathways of chronic kidney diseases, implications for therapeutics

Q Yuan, B Tang, C Zhang - Signal transduction and targeted therapy, 2022 - nature.com
Chronic kidney disease (CKD) is a chronic renal dysfunction syndrome that is characterized
by nephron loss, inflammation, myofibroblasts activation, and extracellular matrix (ECM) …

Incretin drugs in diabetic kidney disease: biological mechanisms and clinical evidence

RZ Alicic, EJ Cox, JJ Neumiller, KR Tuttle - Nature Reviews Nephrology, 2021 - nature.com
As the prevalence of diabetes continues to climb, the number of individuals living with
diabetic complications will reach an unprecedented magnitude. The emergence of new …

[HTML][HTML] Immune responses in diabetic nephropathy: Pathogenic mechanisms and therapeutic target

J Chen, Q Liu, J He, Y Li - Frontiers in Immunology, 2022 - frontiersin.org
Diabetic nephropathy (DN) is a chronic, inflammatory disease affecting millions of diabetic
patients worldwide. DN is associated with proteinuria and progressive slowing of glomerular …

[HTML][HTML] Podocyte-specific Nlrp3 inflammasome activation promotes diabetic kidney disease

K Shahzad, S Fatima, H Khawaja, A Elwakiel, I Gadi… - Kidney International, 2022 - Elsevier
Efficient therapies for diabetic kidney disease (DKD), now the leading cause of kidney
failure, are lacking. One hallmark of DKD is sterile inflammation (inflammation in absence of …

Update on diagnosis, pathophysiology, and management of diabetic kidney disease

M Sugahara, WLW Pak, T Tanaka, SCW Tang… - …, 2021 - Wiley Online Library
Diabetic kidney disease (DKD) is a chronic complication of diabetes mellitus which may
eventually lead to end‐stage kidney disease (ESKD). Despite improvements in glycaemic …

[HTML][HTML] Roles and crosstalks of macrophages in diabetic nephropathy

HD Li, YK You, BY Shao, WF Wu, YF Wang… - Frontiers in …, 2022 - frontiersin.org
Diabetic nephropathy (DN) is the most common chronic kidney disease. Accumulation of
glucose and metabolites activates resident macrophages in kidneys. Resident macrophages …

[HTML][HTML] Dapagliflozin restores impaired autophagy and suppresses inflammation in high glucose-treated HK-2 cells

J Xu, M Kitada, Y Ogura, H Liu, D Koya - Cells, 2021 - mdpi.com
Sodium-glucose cotransporter2 (SGLT2) inhibitors have a reno-protective effect in diabetic
kidney disease. However, the detailed mechanism remains unclear. In this study, human …

[HTML][HTML] Berberine: a review of its pharmacokinetics properties and therapeutic potentials in diverse vascular diseases

X Ai, P Yu, L Peng, L Luo, J Liu, S Li, X Lai… - Frontiers in …, 2021 - frontiersin.org
Traditional Chinese medicine plays a significant role in the treatment of various diseases
and has attracted increasing attention for clinical applications. Vascular diseases affecting …

[HTML][HTML] Molecular mechanisms of diabetic kidney disease

J Rico-Fontalvo, G Aroca, J Cabrales… - International Journal of …, 2022 - mdpi.com
The inflammatory component of diabetic kidney disease has become of great interest in
recent years, with genetic and epigenetic variants playing a fundamental role in the initiation …